Impact of Chronic Total Occlusions on Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous

James Xu1, Amitkumar Patel2, Perwaiz Meraj2

  • 1Department of Cardiology, North Shore University Hospital, Northwell Health, Hofstra Northwell School of Medicine, Manhasset, NY, United States of America; Department of Cardiology, Liverpool Hospital, University of New South Wales, Sydney, NSW, Australia.

Insights

Chronic total occlusions (CTOs) in acute myocardial infarction (AMI) patients undergoing percutaneous coronary intervention (PCI) are linked to worse outcomes. This includes higher in-hospital mortality, longer stays, and increased costs, highlighting a higher-risk patient group.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Outcomes Research

Background:

  • Limited contemporary data exists on the impact of chronic total occlusions (CTOs) in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI).
  • Understanding these outcomes is crucial for optimizing treatment strategies in high-risk cardiac patients.

Purpose of the Study:

  • To evaluate the in-hospital outcomes of patients with and without CTOs presenting with AMI who underwent PCI.
  • To identify the specific risks associated with CTOs in this patient population.

Main Methods:

  • A retrospective analysis of the National Inpatient Sample (NIS) database from October 2015 to December 2017.
  • Identification of AMI patients undergoing PCI using ICD-10 codes.
  • A 1:1 propensity-score matched analysis comparing outcomes between patients with and without CTOs.

Main Results:

  • Out of 576,760 admissions, 8.8% had CTOs. After matching, each group had 51,210 admissions.
  • In-hospital mortality was significantly higher in the CTO group (4.7% vs. 3%, p < 0.0001).
  • The CTO group experienced longer hospital stays (median 3 vs. 2 days), lower discharge-to-home rates (78.8% vs. 81.1%), and higher hospitalization costs ($20,921 vs. $19,856).

Conclusions:

  • The presence of CTOs in AMI patients undergoing PCI identifies a significantly higher-risk cohort.
  • CTOs are associated with increased in-hospital mortality, prolonged hospital stays, and greater healthcare costs.
  • These findings underscore the importance of considering CTOs in risk stratification and management of AMI patients undergoing PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
24
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
71
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
43
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
29
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29